A Proven Team, a Decade in the Making

A History of Impact

After the HITECH Act and Accountable Care Act passed in 2009 and 2010, respectively, “digital health” exploded. Within a few short years, the healthcare technology innovation landscape was crowded and incredibly fragmented. On one hand, there was a surplus of entrepreneurs iterating on solutions to the industry’s most pressing challenges. On the other, there was a convoluted web of stakeholders, desperate to find solutions but ill equipped to efficiently recognize the best ones (or build them themselves), introducing even greater inefficiency in the innovation adoption cycle.

In 2015, Allumia Ventures (then Providence Ventures) emerged as the critical bridge to this gap, guiding both top-tier solutions and customers through this complex ecosystem. Born from Providence, we combined unique access to one of the largest, most diversified stakeholder networks in the market with our institutional investment expertise to create a model capturing the best of both worlds, delivering world-class financial and strategic value.

To date, we’ve partnered with 29 companies who work with a variety of stakeholders across healthcare: providers, payors, employers, pharma, and, of course, patients. Every single portfolio company has worked with our LP base, underscoring the value we deliver for our partner companies and investors. But we’re not just investors; we are partners in impact and catalysts for change, driving adoption with deep and targeted reach.

Today, we continue to do what we’ve always done: identifying and introducing best-in-class care models and technologies across the healthcare ecosystem. But in a rapidly changing landscape, we’ve adapted and evolved, too, serving as a critical partner for our LPs as they navigate new challenges and seek the solutions that work. With us, you get the best of both worlds: We are mission-driven, but we’re not an impact fund. We have access to the customer, but we’re not corporate venture capital. We are financial investors with a proven track record of double bottom-line returns. We hope you’ll join us.

Our Values

Mission-Driven and Results-Focused

01 / 04

Partnership

Our companies are our partners in impact, so we give each one the time and attention they deserve.

02 / 04

Innovation

We invest broadly and deeply across the ecosystem because we believe that every facet of healthcare can do more and be better.

03 / 04

Performance

We want every company we partner with to demand results. After all, that’s how we fix healthcare.

04 / 04

Integrity

We’re mission-driven people who like to work with good people, and we don’t sacrifice doing the right thing for gain.

Investing in Healthcare Innovators

We focus on best-in-class commercial-stage healthcare companies that leverage technology to address the industry’s most pressing issues. We specialize in businesses that are poised to deliver venture-class returns while meeting the critical needs of our anchor strategic LP base. Specifically, we look for the following:

Commercial-stage focus

Revenue-generating (typically Series A-C)

Investment amount

$5-10M+ (initial investment), with up to $15M total

Geographical focus

United States (including ex-US companies with a majority focus in the US)

Sector focus

Digital Health, Tech-enabled Healthcare Services, MedTech

Lead/syndicate

Prefer to lead or co-lead but can participate in syndicate as well, depending on deal dynamics

Board participation

Prefer taking board seats

Explore Our Approach